| Cover | Nov. 01, 2024 |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 01, 2024 |
| Entity File Number | 001-40101 |
| Entity Registrant Name | BRIACELL THERAPEUTICS CORP. |
| Entity Central Index Key | 0001610820 |
| Entity Tax Identification Number | 47-1099599 |
| Entity Incorporation, State or Country Code | A1 |
| Entity Address, Address Line One | Suite 300 - 235 15th Street |
| Entity Address, City or Town | West Vancouver |
| Entity Address, State or Province | BC |
| Entity Address, Postal Zip Code | V7T 2X1 |
| City Area Code | (604) |
| Local Phone Number | 921-1810 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
| Common Shares, no par value | |
| Title of 12(b) Security | Common Shares, no par value |
| Trading Symbol | BCTX |
| Security Exchange Name | NASDAQ |
| Warrants to purchase common shares, no par value | |
| Title of 12(b) Security | Warrants to purchase common shares, no par value |
| Trading Symbol | BCTXW |
| Security Exchange Name | NASDAQ |
